231 related articles for article (PubMed ID: 19435650)
1. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior.
Pereira Do Carmo G; Stevenson GW; Carlezon WA; Negus SS
Pain; 2009 Jul; 144(1-2):170-7. PubMed ID: 19435650
[TBL] [Abstract][Full Text] [Related]
2. Effects of μ-opioid receptor agonists in assays of acute pain-stimulated and pain-depressed behavior in male rats: role of μ-agonist efficacy and noxious stimulus intensity.
Altarifi AA; Rice KC; Negus SS
J Pharmacol Exp Ther; 2015 Feb; 352(2):208-17. PubMed ID: 25406170
[TBL] [Abstract][Full Text] [Related]
3. Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.
Altarifi AA; Negus SS
Eur J Pharmacol; 2015 Feb; 748():76-82. PubMed ID: 25530266
[TBL] [Abstract][Full Text] [Related]
4. Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.
Rosenberg MB; Carroll FI; Negus SS
J Pain; 2013 Mar; 14(3):246-59. PubMed ID: 23332494
[TBL] [Abstract][Full Text] [Related]
5. Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.
Negus SS; Rosenberg MB; Altarifi AA; O'Connell RH; Folk JE; Rice KC
J Pain; 2012 Apr; 13(4):317-27. PubMed ID: 22424913
[TBL] [Abstract][Full Text] [Related]
6. Abuse-related effects of µ-opioid analgesics in an assay of intracranial self-stimulation in rats: modulation by chronic morphine exposure.
Altarifi AA; Rice KC; Negus SS
Behav Pharmacol; 2013 Sep; 24(5-6):459-70. PubMed ID: 23881045
[TBL] [Abstract][Full Text] [Related]
7. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.
Negus SS; Morrissey EM; Rosenberg M; Cheng K; Rice KC
Psychopharmacology (Berl); 2010 Jun; 210(2):149-59. PubMed ID: 20101391
[TBL] [Abstract][Full Text] [Related]
8. Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.
Freitas KC; Carroll FI; Negus SS
J Pharmacol Exp Ther; 2015 Nov; 355(2):341-50. PubMed ID: 26359313
[TBL] [Abstract][Full Text] [Related]
9. Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.
Kwilasz AJ; Negus SS
J Pharmacol Exp Ther; 2012 Nov; 343(2):389-400. PubMed ID: 22892341
[TBL] [Abstract][Full Text] [Related]
10. Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.
Lazenka ML; Moerke MJ; Townsend EA; Freeman KB; Carroll FI; Negus SS
Psychopharmacology (Berl); 2018 Jan; 235(1):203-213. PubMed ID: 29063139
[TBL] [Abstract][Full Text] [Related]
11. Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.
Lazenka MF; Freitas KC; Henck S; Negus SS
J Pharmacol Exp Ther; 2017 Jul; 362(1):14-23. PubMed ID: 28411257
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.
Leitl MD; Negus SS
Behav Pharmacol; 2016 Jun; 27(4):364-76. PubMed ID: 26588213
[TBL] [Abstract][Full Text] [Related]
13. Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats.
Leitl MD; Potter DN; Cheng K; Rice KC; Carlezon WA; Negus SS
Mol Pain; 2014 Sep; 10():62. PubMed ID: 25245060
[TBL] [Abstract][Full Text] [Related]
14. Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam.
Moerke MJ; Li G; Golani LK; Cook J; Negus SS
Behav Pharmacol; 2019 Aug; 30(5):452-461. PubMed ID: 30640180
[TBL] [Abstract][Full Text] [Related]
15. Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.
Legakis LP; Karim-Nejad L; Negus SS
Psychopharmacology (Berl); 2020 Jul; 237(7):2201-2212. PubMed ID: 32382785
[TBL] [Abstract][Full Text] [Related]
16. Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids.
Leitl MD; Onvani S; Bowers MS; Cheng K; Rice KC; Carlezon WA; Banks ML; Negus SS
Neuropsychopharmacology; 2014 Feb; 39(3):614-24. PubMed ID: 24008352
[TBL] [Abstract][Full Text] [Related]
17. Effects of repeated morphine on intracranial self-stimulation in male rats in the absence or presence of a noxious pain stimulus.
Miller LL; Altarifi AA; Negus SS
Exp Clin Psychopharmacol; 2015 Oct; 23(5):405-14. PubMed ID: 26375515
[TBL] [Abstract][Full Text] [Related]
18. Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.
Stevenson GW; Cormier J; Mercer H; Adams C; Dunbar C; Negus SS; Bilsky EJ
Life Sci; 2009 Aug; 85(7-8):309-15. PubMed ID: 19559034
[TBL] [Abstract][Full Text] [Related]
19. Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence.
Altarifi AA; Negus SS
Behav Pharmacol; 2011 Oct; 22(7):663-73. PubMed ID: 21921839
[TBL] [Abstract][Full Text] [Related]
20. The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats.
Do Carmo GP; Folk JE; Rice KC; Chartoff E; Carlezon WA; Negus SS
Eur J Pharmacol; 2009 Feb; 604(1-3):58-65. PubMed ID: 19133255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
